289 related articles for article (PubMed ID: 21930189)
1. Spectrofluorimetric analysis of the interaction of amyloid peptides with neuronal nitric oxide synthase: implications in Alzheimer's disease.
Padayachee ER; Whiteley CG
Biochim Biophys Acta; 2011 Dec; 1810(12):1136-40. PubMed ID: 21930189
[TBL] [Abstract][Full Text] [Related]
2. Etiology of Alzheimer's disease: kinetic, thermodynamic and fluorimetric analyses of interactions of pseudo Aβ-peptides with neuronal nitric oxide synthase.
Padayachee ER; Whiteley CG
Neuropeptides; 2013 Oct; 47(5):321-7. PubMed ID: 24034554
[TBL] [Abstract][Full Text] [Related]
3. Interaction of glycine zipper fragments of Aβ-peptides with neuronal nitric oxide synthase: kinetic, thermodynamic and spectrofluorimetric analysis.
Padayachee ER; Whiteley CG
Neuropeptides; 2013 Jun; 47(3):171-8. PubMed ID: 23375441
[TBL] [Abstract][Full Text] [Related]
4. Arginine metabolising enzymes as targets against Alzheimers' disease.
Whiteley CG
Neurochem Int; 2014 Feb; 67():23-31. PubMed ID: 24508404
[TBL] [Abstract][Full Text] [Related]
5. Arginine metabolising enzymes as therapeutic tools for Alzheimer's disease: peptidyl arginine deiminase catalyses fibrillogenesis of beta-amyloid peptides.
Mohlake P; Whiteley CG
Mol Neurobiol; 2010 Jun; 41(2-3):149-58. PubMed ID: 20224908
[TBL] [Abstract][Full Text] [Related]
6. Association of β-amyloid peptide fragments with neuronal nitric oxide synthase: Implications in the etiology of Alzheimers disease.
Padayachee E; Ngqwala N; Whiteley CG
J Enzyme Inhib Med Chem; 2012 Jun; 27(3):356-64. PubMed ID: 21699461
[TBL] [Abstract][Full Text] [Related]
7. Interaction of superoxide dismutase with the glycine zipper regions of β-amyloid peptides: is there an implication towards Alzheimer's disease and oxidative stress?
Oyatsi F; Whiteley CG
J Enzyme Inhib Med Chem; 2013 Aug; 28(4):727-33. PubMed ID: 22524677
[TBL] [Abstract][Full Text] [Related]
8. Nanomedicine: action of metal nanoparticles on neuronal nitric oxide synthase-fluorimetric analysis on the mechanism for fibrillogenesis.
Padayachee ER; Arowolo A; Whiteley CG
Neurochem Res; 2014 Jan; 39(1):194-201. PubMed ID: 24293250
[TBL] [Abstract][Full Text] [Related]
9. Role of N-terminal residues in Aβ interactions with integrin receptor and cell surface.
Venkatasubramaniam A; Drude A; Good T
Biochim Biophys Acta; 2014 Oct; 1838(10):2568-77. PubMed ID: 24955499
[TBL] [Abstract][Full Text] [Related]
10. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
11. Identification of peptides that specifically bind Abeta1-40 amyloid in vitro and amyloid plaques in Alzheimer's disease brain using phage display.
Kang CK; Jayasinha V; Martin PT
Neurobiol Dis; 2003 Oct; 14(1):146-56. PubMed ID: 13678675
[TBL] [Abstract][Full Text] [Related]
12. Engineered non-fluorescent Affibody molecules facilitate studies of the amyloid-beta (Aβ) peptide in monomeric form: low pH was found to reduce Aβ/Cu(II) binding affinity.
Lindgren J; Segerfeldt P; Sholts SB; Gräslund A; Karlström AE; Wärmländer SK
J Inorg Biochem; 2013 Mar; 120():18-23. PubMed ID: 23262458
[TBL] [Abstract][Full Text] [Related]
13. Fluorimetric detection of the earliest events in amyloid β oligomerization and its inhibition by pharmacologically active liposomes.
Nardo L; Re F; Brioschi S; Cazzaniga E; Orlando A; Minniti S; Lamperti M; Gregori M; Cassina V; Brogioli D; Salerno D; Mantegazza F
Biochim Biophys Acta; 2016 Apr; 1860(4):746-56. PubMed ID: 26774643
[TBL] [Abstract][Full Text] [Related]
14. The synaptic protein neuroligin-1 interacts with the amyloid β-peptide. Is there a role in Alzheimer's disease?
Dinamarca MC; Weinstein D; Monasterio O; Inestrosa NC
Biochemistry; 2011 Sep; 50(38):8127-37. PubMed ID: 21838267
[TBL] [Abstract][Full Text] [Related]
15. Substituted tryptophans at amyloid-β(1-40) residues 19 and 20 experience different environments after fibril formation.
McDonough RT; Paranjape G; Gallazzi F; Nichols MR
Arch Biochem Biophys; 2011 Oct; 514(1-2):27-32. PubMed ID: 21843498
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of beta-amyloid(40) fibrillogenesis and disassembly of beta-amyloid(40) fibrils by short beta-amyloid congeners containing N-methyl amino acids at alternate residues.
Gordon DJ; Sciarretta KL; Meredith SC
Biochemistry; 2001 Jul; 40(28):8237-45. PubMed ID: 11444969
[TBL] [Abstract][Full Text] [Related]
17. Alzheimer's disease amyloid β-protein mutations and deletions that define neuronal binding/internalization as early stage nonfibrillar/fibrillar aggregates and late stage fibrils.
Poduslo JF; Howell KG; Olson NC; Ramirez-Alvarado M; Kandimalla KK
Biochemistry; 2012 May; 51(19):3993-4003. PubMed ID: 22545812
[TBL] [Abstract][Full Text] [Related]
18. Methionine 35 oxidation reduces fibril assembly of the amyloid abeta-(1-42) peptide of Alzheimer's disease.
Hou L; Kang I; Marchant RE; Zagorski MG
J Biol Chem; 2002 Oct; 277(43):40173-6. PubMed ID: 12198111
[TBL] [Abstract][Full Text] [Related]
19. Copper mediates dityrosine cross-linking of Alzheimer's amyloid-beta.
Atwood CS; Perry G; Zeng H; Kato Y; Jones WD; Ling KQ; Huang X; Moir RD; Wang D; Sayre LM; Smith MA; Chen SG; Bush AI
Biochemistry; 2004 Jan; 43(2):560-8. PubMed ID: 14717612
[TBL] [Abstract][Full Text] [Related]
20. In vivo SPECT imaging of amyloid-β deposition with radioiodinated imidazo[1,2-a]pyridine derivative DRM106 in a mouse model of Alzheimer's disease.
Chen CJ; Bando K; Ashino H; Taguchi K; Shiraishi H; Shima K; Fujimoto O; Kitamura C; Matsushima S; Uchida K; Nakahara Y; Kasahara H; Minamizawa T; Jiang C; Zhang MR; Ono M; Tokunaga M; Suhara T; Higuchi M; Yamada K; Ji B
J Nucl Med; 2015 Jan; 56(1):120-6. PubMed ID: 25476539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
